 | • レポートコード： • 出版社/出版日： / • レポート形態：、、ページ数はお問い合わせください。 • 納品方法： |
| ￥ 日本円の価格はお問い合わせください。 (0) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
Adhesion Barriers Market – Scope of Report
TMR’s report on the global adhesion barriers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global adhesion barriers market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global adhesion barriers market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the adhesion barriers market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global adhesion barriers market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global adhesion barriers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global adhesion barriers market.
Tadhesion barriershe report delves into the competitive landscape of the global adhesion barriers market. Key players operating in the global adhesion barriers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global adhesion barriers market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market adhesion barriers.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Adhesion Barriers Market Forecast
4.4. Global Adhesion Barriers Market Outlook
5. Market Outlook
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/globally
5.3. Key Industry Developments
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Adhesion Barriers Market Analysis and Forecast, by Type
6.1. Introduction
6.2. Global Adhesion Barriers Market Value Share and Attractiveness Analysis, by Type
6.3. Global Adhesion Barriers Market Forecast, by Type
6.3.1. Natural Adhesion Barriers
6.3.1.1. Collagen & Protein
6.3.1.2. Fibrin
6.3.2. Synthetic Adhesion Barriers
6.3.2.1. Hyaluronic Acid
6.3.2.2. Regenerated Cellulose
6.3.2.3. Polyethylene Glycol
6.3.2.4. Other Synthetic Adhesion Barriers
7. Global Adhesion Barriers Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Global Adhesion Barriers Market Value Share and Attractiveness Analysis, by Application
7.2.1. Abdominal Surgeries
7.2.2. Gynecological Surgeries
7.2.3. Neuro Surgeries
7.3.4. Orthopedic Surgeries
7.3.5. Others
8. Global Adhesion Barriers Market Analysis and Forecast, by Formulation
8.1. Introduction
8.2. Global Adhesion Barriers Market Value Share and Attractiveness Analysis, by Formulation
8.2.1. Film
8.2.2. Gel
8.2.3. Liquid
9. Global Adhesion Barriers Market Analysis and Forecast, by End-user
9.1. Introduction
9.2. Global Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
9.2.1. Ambulatory Surgery Centers
9.2.2. Hospitals
9.2.3. Specialty Clinics
10. Global Adhesion Barriers Market Analysis and Forecast, by Region
10.1. North America
10.2. Europe
10.3. Asia Pacific
10.4. Latin America
10.5. Middle East & Africa
11. North America Adhesion Barriers Market Analysis
11.1. North America Adhesion Barriers Market Overview
11.2. North America Adhesion Barriers Market Value Share and Attractiveness Analysis, by Country
11.3. North America Adhesion Barriers Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Adhesion Barriers Market Value Share and Attractiveness Analysis, by Type
11.5. North America Adhesion Barriers Market Forecast, by Type
11.5.1. Natural Adhesion Barriers
11.5.1.1. Collagen & Protein
11.5.1.2. Fibrin
11.5.2. Synthetic Adhesion Barriers
11.5.2.1. Hyaluronic Acid
11.5.2.2. Regenerated Cellulose
11.5.2.3. Polyethylene Glycol
11.5.2.4. Other Synthetic Adhesion Barriers
11.6. North America Adhesion Barriers Market Value Share and Attractiveness Analysis, by Application
11.7. North America Adhesion Barriers Market Forecast, by Application
11.7.1. Abdominal Surgeries
11.7.2. Gynecological Surgeries
11.7.3. Neuro Surgeries
11.7.4. Orthopedic Surgeries
11.7.5. Others
11.8. North America Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
11.9. North America Adhesion Barriers Market Forecast, by Formulation
11.9.1. Film
11.9.2. Gel
11.9.3. Liquid
11.10. North America Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
11.11. North America Adhesion Barriers Market Forecast, by End-user
11.11.1. Ambulatory Surgery Centers
11.11.2. Hospitals
11.11.3. Specialty Clinics
12. Europe Adhesion Barriers Market Analysis
12.1. Europe Adhesion Barriers Market Overview
12.2. Europe Adhesion Barriers Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Europe Adhesion Barriers Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Adhesion Barriers Market Value Share and Attractiveness Analysis, by Type
12.5. Europe Adhesion Barriers Market Forecast, by Type
12.5.1. Natural Adhesion Barriers
12.5.1.1. Collagen & Protein
12.5.1.2. Fibrin
12.5.2. Synthetic Adhesion Barriers
12.5.2.1. Hyaluronic Acid
12.5.2.2. Regenerated Cellulose
12.5.2.3. Polyethylene Glycol
12.5.2.4. Other Synthetic Adhesion Barriers
12.6. Europe Adhesion Barriers Market Value Share and Attractiveness Analysis, by Application
12.7. Europe Adhesion Barriers Market Forecast, by Application
12.7.1. Abdominal Surgeries
12.7.2. Gynecological Surgeries
12.7.3. Neuro Surgeries
12.7.4. Orthopedic Surgeries
12.7.5. Others
12.8. Europe Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
12.9. Europe Adhesion Barriers Market Forecast, by Formulation
12.9.1. Film
12.9.2. Gel
12.9.3. Liquid
12.10. Europe Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
12.11. Europe Adhesion Barriers Market Forecast, by End-user
12.11.1. Ambulatory Surgery Centers
12.11.2. Hospitals
12.11.3. Specialty Clinics
13. Asia Pacific Adhesion Barriers Market Analysis
13.1. Asia Pacific Adhesion Barriers Market Overview
13.2. Asia Pacific Adhesion Barriers Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Asia Pacific Adhesion Barriers Market Forecast, by Country/Sub-region
13.3.1. Japan
13.3.2. China
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Adhesion Barriers Market Value Share and Attractiveness Analysis, by Type
13.5. Asia Pacific Adhesion Barriers Market Forecast, by Type
13.5.1. Natural Adhesion Barriers
13.5.1.1. Collagen & Protein
13.5.1.2. Fibrin
13.5.2. Synthetic Adhesion Barriers
13.5.2.1. Hyaluronic Acid
13.5.2.2. Regenerated Cellulose
13.5.2.3. Polyethylene Glycol
13.5.2.4. Other Synthetic Adhesion Barriers
13.6. Asia Pacific Adhesion Barriers Market Value Share and Attractiveness Analysis, by Application
13.7. Asia Pacific Adhesion Barriers Market Forecast, by Application
13.7.1. Abdominal Surgeries
13.7.2. Gynecological Surgeries
13.7.3. Neuro Surgeries
13.7.4. Orthopedic Surgeries
13.7.5. Others
13.8. Asia Pacific Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
13.9. Asia Pacific Adhesion Barriers Market Forecast, by Formulation
13.9.1. Film
13.9.2. Gel
13.9.3. Liquid
13.10. Asia Pacific Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
13.11. Asia Pacific Adhesion Barriers Market Forecast, by End-user
13.11.1. Ambulatory Surgery Centers
13.11.2. Hospitals
13.11.3. Specialty Clinics
14. Latin America Adhesion Barriers Market Analysis
14.1. Latin America Adhesion Barriers Market Overview
14.2. Latin America Adhesion Barriers Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Latin America Adhesion Barriers Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Adhesion Barriers Market Value Share and Attractiveness Analysis, by Type
14.5. Latin America Adhesion Barriers Market Forecast, by Type
14.5.1. Natural Adhesion Barriers
14.5.1.1. Collagen & Protein
14.5.1.2. Fibrin
14.5.2. Synthetic Adhesion Barriers
14.5.2.1. Hyaluronic Acid
14.5.2.2. Regenerated Cellulose
14.5.2.3. Polyethylene Glycol
14.5.2.4. Other Synthetic Adhesion Barriers
14.6. Latin America Adhesion Barriers Market Value Share and Attractiveness Analysis, by Application
14.7. Latin America Adhesion Barriers Market Forecast, by Application
14.7.1. Abdominal Surgeries
14.7.2. Gynecological Surgeries
14.7.3. Neuro Surgeries
14.7.4. Orthopedic Surgeries
14.7.5. Others
14.8. Latin America Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
14.9. Latin America Adhesion Barriers Market Forecast, by Formulation
14.9.1. Film
14.9.2. Gel
14.9.3. Liquid
14.10. Latin America Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
14.11. Latin America Adhesion Barriers Market Forecast, by End-user
14.11.1. Ambulatory Surgery Centers
14.11.2. Hospitals
14.11.3. Specialty Clinics
15. Middle East & Africa Adhesion Barriers Market Analysis
15.1. Middle East & Africa Adhesion Barriers Market Overview
15.2. Middle East & Africa Adhesion Barriers Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Middle East & Africa Adhesion Barriers Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of MEA
15.4. Middle East & Africa Adhesion Barriers Market Value Share and Attractiveness Analysis, by Type
15.5. Middle East & Africa Adhesion Barriers Market Forecast, by Type
15.5.1. Natural Adhesion Barriers
15.5.1.1. Collagen & Protein
15.5.1.2. Fibrin
15.5.2. Synthetic Adhesion Barriers
15.5.2.1. Hyaluronic Acid
15.5.2.2. Regenerated Cellulose
15.5.2.3. Polyethylene Glycol
15.5.2.4. Other Synthetic Adhesion Barriers
15.6. Middle East & Africa Adhesion Barriers Market Value Share and Attractiveness Analysis, by Application
15.7. Middle East & Africa Adhesion Barriers Market Forecast, by Application
15.7.1. Abdominal Surgeries
15.7.2. Gynecological Surgeries
15.7.3. Neuro Surgeries
15.7.4. Orthopedic Surgeries
15.7.5. Others
15.8. Middle East & Africa Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
15.9. Middle East & Africa Adhesion Barriers Market Forecast, by Formulation
15.9.1. Film
15.9.2. Gel
15.9.3. Liquid
15.10. Middle East & Africa Adhesion Barriers Market Value Share and Attractiveness Analysis, by End-user
15.11. Middle East & Africa Adhesion Barriers Market Forecast, by End-user
15.11.1. Ambulatory Surgery Centers
15.11.2. Hospitals
15.11.3. Specialty Clinics
16. Competitive Analysis
16.1. Competition Matrix
16.2. Global Albumin (as Excipient) Market, Company Share Analysis
16.3. Company Profile
16.3.1. Becton, Dickinson and Company.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. Allosource
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. Baxter International, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. Anika Therapeutics
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Ethicon US, LLC
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Hangzhou Singclean Medical Products Co., Ltd.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.2.4.Strategic Overview
16.3.7. Integra LifeSciences Corporation
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. PlantTec Medical GmbH
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview
16.3.9. Sanofi
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. Innocoll
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview
16.3.11. Terumo Corporation
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Strategic Overview
16.3.12. FzioMed, Inc.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. SWOT Analysis
16.3.12.4. Strategic Overview